Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms

被引:63
作者
Arbiser, JL
Brat, D
Hunter, S
D'Armiento, J
Henske, EP
Arbiser, ZK
Bai, XH
Goldberg, G
Cohen, C
Weiss, SW
机构
[1] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA
[3] Columbia Univ, Dept Med, New York, NY USA
[4] Univ Penn, Fox Chase Canc Ctr, Philadelphia, PA 19104 USA
[5] Univ Arizona, Hlth Sci Ctr, Dept Pediat, Tucson, AZ 85721 USA
[6] Univ Arizona, Hlth Sci Ctr, Dept Dermatol, Tucson, AZ 85721 USA
关键词
D O I
10.1067/mjd.2002.120530
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Tuberous sclerosis is an autosomal dominant condition characterized by the development of benign neoplasms of the brain, kidney, and skin. Progressive growth and malignant transformation of brain and kidney lesions constitute the major cause of morbidity and mortality in adults with tuberous sclerosis. In addition, growth of skin lesions may be disfiguring to patients. Objective: The purpose of this study was to determine whether benign tumors in patients with tuberous sclerosis are angiogenic. Methods: Brain, kidney, and skin tumors from patients with tuberous sclerosis were stained with CD31, a specific marker of vascular endothelium. In addition, we used Northern blot analysis to demonstrate that renal angiomyolipoma cells express the potent angiogenesis stimulator vascular endothelial growth factor (VEGF). Results: Brain, kidney; and skin neoplasms from patients with tuberous sclerosis are highly angiogenic. Renal angiomyolipoma cells produce the potent angiogenic factor VEGF. Conclusion: Benign neoplasms of patients with tuberous sclerosis are highly vascular. Our results provide a rationale for antiangiogenic therapy in the treatment anti prevention of tuberous sclerosis-associated neoplasms.
引用
收藏
页码:376 / 380
页数:5
相关论文
共 33 条
  • [1] Al-Saleem T, 1998, CANCER-AM CANCER SOC, V83, P2208, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2208::AID-CNCR21>3.0.CO
  • [2] 2-K
  • [3] Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin
    Arbiser, JL
    Karalis, K
    Viswanathan, A
    Koike, C
    Anand-Apte, B
    Flynn, E
    Zetter, B
    Majzoub, JA
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (05) : 838 - 842
  • [4] Angiogenesis and the skin: A primer
    Arbiser, JL
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (03) : 486 - 497
  • [5] Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
    Arbiser, JL
    Moses, MA
    Fernandez, CA
    Ghiso, N
    Cao, YH
    Klauber, N
    Frank, D
    Brownlee, M
    Flynn, E
    Parangi, S
    Byers, HR
    Folkman, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (03) : 861 - 866
  • [6] Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo
    Arbiser, JL
    Larsson, H
    Claesson-Welsh, L
    Bai, XH
    LaMontagne, K
    Weiss, SW
    Soker, S
    Flynn, E
    Brown, LF
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04) : 1469 - 1476
  • [7] Curcumin is an in vivo inhibitor of angiogenesis
    Arbiser, JL
    Klauber, N
    Rohan, R
    van Leeuwen, R
    Huang, MT
    Fisher, C
    Flynn, E
    Byers, HR
    [J]. MOLECULAR MEDICINE, 1998, 4 (06) : 376 - 383
  • [8] Analysis of vascularity of human neurofibromas
    Arbiser, JL
    Flynn, E
    Barnhill, RL
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (06) : 950 - 954
  • [9] Angiogenesis inhibited by drinking tea
    Cao, YH
    Cao, RH
    [J]. NATURE, 1999, 398 (6726) : 381 - 381
  • [10] Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1
    Darling, TN
    Skarulis, MC
    Steinberg, SM
    Marx, SJ
    Spiegel, AM
    Turner, M
    [J]. ARCHIVES OF DERMATOLOGY, 1997, 133 (07) : 853 - 857